For other tracers, such as F-18-DCFPyL and F-18-PSMA-1007, images at 120 min after injection presented a higher detection rate of prostate cancer characteristic lesions than images at 60 min after injection. The gene discussed is FOLH1; the disease is prostate carcinoma.